🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of CC-486 ...
Status
Completed
Location
Winship Cancer Institute of Emory University
Start Date
2015-02-13
Trial ID
NCT02269943
Treatments Being Tested
Phase II randomized open-label, two-arm study of safety and efficacy of CC-...
Status
Completed
Location
University of Colorado Health Science Center
Start Date
2003-09
Trial ID
NCT00072722
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of induction the...
Status
Completed
Location
Duke University Medical Center
Start Date
2008-08
Trial ID
NCT00691704
Treatments Being Tested
A study to collect survival data on patients previously enrolled in Abraxan...
Status
Completed
Location
TGen Clinical Research Services
Start Date
2014-01-02
Trial ID
NCT02021500
Treatments Being Tested
The purpose of the study is to determine the best treatment approach based ...
Status
Not Yet Recruiting
Location
Beth Israel Deaconess Medical Center (BIDMC)
Start Date
2026-06-08
Trial ID
NCT07624513
Objective of this study is to characterize the steady-state pharmacokinetic...
Status
Completed
Location
Hopital Augustin Morvan
Start Date
2013-11-07
Trial ID
NCT01937442
Treatments Being Tested
The primary purpose of this study is to determine the effectiveness and saf...
Status
Completed
Location
Changhua Christian Hospital
Start Date
2010-10-01
Trial ID
NCT01201811
Treatments Being Tested
Evaluate the safety and efficacy of oral azacitidne (CC-486) twice daily (B...
Status
Completed
Location
Local Institution - 113
Start Date
2015-07-06
Trial ID
NCT02281084
Treatments Being Tested
Study will deteremine the MTD and evaluate the safety profile of oral lenal...
Status
Terminated
Location
MD Anderson - Orlando
Start Date
2005-09
Trial ID
NCT00179699
Treatments Being Tested
Maintenance treatment of advanced stage squamous cell NSCLC. Phase III, ra...
Status
Completed
Location
Clearview Cancer Institute Oncology Specialties, P.C
Start Date
2014-02-11
Trial ID
NCT02027428